$IOVA LUN-202 my take after the Wells Fargo discussion:
1. Management sounds highly confident ORR stays around ~25%. They essentially suggested the larger Q4 dataset should look very similar to the current 25.6%. That meaningfully reduces the risk of an efficacy collapse as
